Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by laroplexon May 26, 2024 10:38am
266 Views
Post# 36057893

RE:RE:ONCY presents 2 posters at ASCO 2024

RE:RE:ONCY presents 2 posters at ASCO 2024These 2 posters ONCY is presenting on Saturday should be key to attracting that big Pharma partner we have all been waiting for(buy-out or partnership).....I got a gut feeling our s/p willl start to explode very very soon, possibly next week in anticipation(news should hit the wire sometime next week).....nonetheless, looking forward to ONCY presenting at ASCO...And btw Noteable, such a gift you bring us longs here, doing all our d/d for us, saving us months and months of digging( possibly not even knowing where to start at first)....I top my hat to you my friend, sincerely......GLTA
<< Previous
Bullboard Posts
Next >>